Serum beta‐defensin‐2 is a biomarker for psoriasis but not subclinical atherosclerosis: Role of IL17a, PI‐3 kinase and Rac1

Serum beta‐defensin‐2 is a biomarker for psoriasis but not subclinical atherosclerosis: Role of IL17a, PI‐3 kinase and Rac1

Abstract Background Beta‐defensins (BDs) are antimicrobial peptides secreted upon epithelial injury. Both chemotactic and antimicrobial properties of BDs function as initial steps in host defence and prime the adaptive immune system in the body. Psoriasis, a chronic immune‐mediated inflammatory dise...

Full description

Bibliographic Details
Main Authors: Carla J. Pantoja, Haiou Li, Justin Rodante, Andrew Keel, Alexander V. Sorokin, Axel Svedbom, Heather L. Teague, Mona Stahle, Nehal N. Mehta, Martin P. Playford
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:JEADV Clinical Practice
Subjects:
atherosclerosis
beta‐defensin
interleukin‐17
PI‐3 kinase
psoriasis
Rac1
Online Access:https://doi.org/10.1002/jvc2.278

Internet

https://doi.org/10.1002/jvc2.278

Similar Items